Biora Therapeutics, Inc. (BIOR) scores 27 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $-81.2, representing a 100% margin of safety.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.